Bespoke Extracts, Inc.

BSPK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $60.3K $6.6K $24.4K $148.2K $126.6K $10.3K $79.8K $87.2K
Accounts Receivable $57.3K $45.2K — $3.6K $3.6K $6.5K $2.0K —
Inventory $32.5K $15.8K — $46.8K — $3.2K $61.9K —
Total Current Assets $165.3K $81.8K $111.7K $2.1M $132.5K $37.6K $174.6K $107.1K
Property, Plant & Equipment $31.3K $41.0K $9.9K $2.7K — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $359.1K $354.4K $409.6K $2.5M $166.2K $79.4K $219.8K $155.6K
Liabilities
Accounts Payable $958.3K $961.3K $295.8K $82.7K $59.9K $111.1K $105.4K $36.5K
Total Current Liabilities $1.1M $1.1M $865.6K $220.0K $679.9K $111.1K $566.2K $234.6K
Long-Term Debt — — — — — — — —
Total Liabilities $2.5M $2.1M $1.1M $500.4K $679.9K $111.1K $647.3K $427.7K
Stockholders' Equity
Retained Earnings $-26.4M $-25.4M $-23.9M $-19.8M $-18.8M $-14.1M $-16.7M $-9.1M
Total Stockholders' Equity $-2.1M $-1.7M $-672.1K $2.0M $-513.7K $-31.6K $-427.5K $-272.1K
← Newer Page 1 of 2 Older →